Vnitr Lek 2016, 62(Suppl 3):63-67

Are the thyroid hormones and thyrotropin associated with cardiometabolic risks and insulin resistance even in euthyroid subjects?

Vojtěch Hainer1,*, Hana Zamrazilová1, Irena Aldhoon Hainerová1,2
1 Centrum pro diagnostiku a léčbu obezity Endokrinologického ústavu, Praha
2 Klinika dětí a dorostu 3. LF UK a FN Královské Vinohrady, Praha

Associations of both hypothyroidism and subclinical hypothyroidism with metabolic syndrome are well established. Nowadays, more attention has been paid to the role of thyroid hormones and thyrotropin (TSH) within the euthyroid range on the development of cardiometabolic health risks. The paper summarizes current knowledge related to the associations of lower free thyroxine (fT4) level and higher levels of both free triiodothyronine (fT3) and TSH with body adiposity, metabolic syndrome and insulin resistance in euthyroid subjects. In our recent study of obese euthyroid adolescents, we revealed that fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) positively correlated with fT3 and TSH and negatively with fT4. The ratio of fT3 to fT4 was also significantly related to HOMA-IR both in girls (r = 0.347, p < 0.001) and boys (r = 0.267, p < 0.001). It is concluded that up-to-date conducted studies mostly confirmed that thyroid hormones and TSH even in euthyroid range may significantly affect the metabolic health and particularly insulin sensitivity.

Keywords: euthyroid range; insulin resistance; metabolic health; metabolic syndrome; obesity; thyrotropin; thyroxine; triiodothyronine

Received: August 31, 2016; Accepted: September 6, 2016; Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hainer V, Zamrazilová H, Aldhoon Hainerová I. Are the thyroid hormones and thyrotropin associated with cardiometabolic risks and insulin resistance even in euthyroid subjects? Vnitr Lek. 2016;62(Supplementum 3):63-67.
Download citation

References

  1. Zamrazil V. Hypotyreóza: průvodce ošetřujícího lékaře. Maxdorf: Praha 2007. ISBN 978-80-7345-111-0.
  2. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010; 316(2): 165-171. Dostupné z DOI: <http://dx.doi.org/10.1016/j.mce.2009.06.005>. Go to original source... Go to PubMed...
  3. Zamrazil V. Subklinická onemocnění štítné žlázy. Vnitř Lék 2015; 61(10): 873-876. Go to PubMed...
  4. Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132(4): 270-278. Go to original source... Go to PubMed...
  5. Iwen KA, Schroder E, Brabant G. Thyroid hormones and the metabolic syndrome. Eur Thyroid J 2013; 2(2): 83-92. Dostupné z DOI: <http://dx.doi.org/10.1159/000351249>. Go to original source... Go to PubMed...
  6. Van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. Eur J Clin Invest 2015; 45(5): 494-503. Dostupné z DOI: <http://dx.doi.org/10.1111/eci.12423>. Go to original source... Go to PubMed...
  7. Aldhoon-Hainerová I, Zamrazilová H, Hill M et al. Hormones and metabolically healthy obesity. Metabolism 2016. V recenzním řízení.
  8. Knudsen N, Laurberg P, Rasmussen LB et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90(7): 4019-4024. Go to original source... Go to PubMed...
  9. Makepeace AE, Bremner AP, O' Leary P et al. Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: differences between smokers and nonsmokers. Clin Endocrinol (Oxf) 2008; 69(4): 648-652. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2265.2008.03239.x>. Go to original source... Go to PubMed...
  10. Alevizaki M, Saltiki K, Voidonikola P et al. Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals. Eur J Endocrinol 2009; 161(3): 459-465. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-09-0441>. Go to original source... Go to PubMed...
  11. Mehran L, Amouzegar A, Tohidi M et al. Serum free thyroxine is associated with metabolic syndrome in euthyroid subjects. Thyroid 2014; 24(11): 1566-1574. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.2014.0103>. Go to original source... Go to PubMed...
  12. Ren R, Jiang X, Zhang X et al. Association between thyroid hormones and body fat in euthyroid subjects. Clin Endocrinol (Oxf) 2014; 80(4): 585-590. Dostupné z DOI: <http://dx.doi.org/10.1111/cen.12311>. Go to original source... Go to PubMed...
  13. Iacobellis G, Ribaudo MC, Zappaterreno A et al. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin. Clin Endocrinol (Oxf) 2005; 62(4): 487-491. Go to original source... Go to PubMed...
  14. Bjergved L, Jorgensen T, Perrild H et al. Thyroid function and body weight: A community-based longitudinal study. PLoS ONE 2014; 9(4): e93515. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0093515>. Go to original source... Go to PubMed...
  15. Taylor PN, Richmond R, Davies N et al. Paradoxical relationship between body mass index and thyroid hormones levels: A study using Mendelian randomization. J Clin Endocrinol Metab 2016; 101(2): 730-738. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2015-3505>. Go to original source... Go to PubMed...
  16. Kitahara CM, Platz EA, Landeuson PW et al. Body fatness and markers of thyroid function among U.S. men and women. PLoS ONE 2012; 7(4): e34979. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0034979>. Go to original source... Go to PubMed...
  17. Manji N, Boelaert K, Sheppard MC et al. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol (Oxf) 2006; 64(2): 125-128. Go to original source... Go to PubMed...
  18. Bakiner O, Bozkirli E, Cavlak G et al. Are plasma thyroid-stimulating hormone levels associated with degrees of obesity and metabolic syndrome in euthyroid obese patiens? A Turkish cohort study. ISRN Endocrinol 2014; 2014: 803028. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/803028>. Go to original source... Go to PubMed...
  19. De Moura Souza A, Sichieri R. Association between serum TSH concentration within normal range and adiposity. Eur J Endocrinol 2011; 165(1): 11-15. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-11-0261>. Go to original source... Go to PubMed...
  20. Roos A, Bakker SJ, Links TP et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007; 92(2): 491-496. Go to original source... Go to PubMed...
  21. Garduno-Garcia JJ, Alvirde-Garcia U, Lopez-Carrasco G et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 2010; 163(2): 273-278. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-10-0312>. Go to original source... Go to PubMed...
  22. Boekholdt SM, Titan SM, Wiersinga WM et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf) 2010; 72(3): 404-410. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2265.2009.03640.x>. Go to original source... Go to PubMed...
  23. Wang F, Tan Y, Wang C et al. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid function. J Clin Endocrinol Metab 2012; 97(8): 2724-2731. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2012-1133>. Go to original source... Go to PubMed...
  24. Asvold BO, Bjoro T, Vatten LJ. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study. Eur J Endocrinol 2013; 169(1): 73-82. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-13-0087>. Go to original source... Go to PubMed...
  25. Gumieniak O, Perlstein TS, Hopkins PN et al. Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab 2004; 89(7): 3455-3461. Go to original source... Go to PubMed...
  26. Kim BJ, Kim TY, Koh JM et al. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf) 2009; 70(1): 152-160. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2265.2008.03304.x>. Go to original source... Go to PubMed...
  27. Roef GL, Rietzschel ER, Van Daele CM et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid subjects. Thyroid 2014; 24(2): 223-231. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.2013.0314>. Go to original source... Go to PubMed...
  28. Sieminska L, Wojciechowska C, Walczak K et al. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol 2015; 66(5): 394-403. Dostupné z DOI: <http://dx.doi.org/10.5603/EP.2015.0049>. Go to original source... Go to PubMed...
  29. Ambrosi B, Masserini B, Iorio L et al. Relationship of thyroid function with body mass index and insulin resistance in euthyroid obese subjects. J Endocrinol Invest 2010; 33(9): 640-643. Dostupné z DOI: <http://dx.doi.org/10.3275/6952>. Go to original source... Go to PubMed...
  30. Roef G, Lapauw B, Goemaere S et al. Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men. Eur J Endocrinol 2012; 167(5): 719-726. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-12-0447>. Go to original source... Go to PubMed...
  31. Garduno-Garcia J Jr, Camarillo Romero E, Loe Ochoa A et al. Thyroid function is associated with insulin resistance markers in healthy adolescents with risk factors to develop diabetes. Diabetol Metab Syndr 2015; 7: 16. Dostupné z DOI: <http://dx.doi.org/10.1186/s13098-015-0011-x>. Go to original source... Go to PubMed...
  32. Marton E, Hadjidakis DJ, Kollias A et al. Studies on insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009; 160(5): 785-790. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-08-0797>. Go to original source... Go to PubMed...
  33. Aldhoon-Hainerová I, Zamrazilová H, Dušátková L. et al. Glucose homeostasis and insulin resistance: prevalence, gender differences and predictors in adolescents. Diabetol Metab Syndr 2014; 6(1): 100. Dostupné z DOI: <http://dx.doi.org/10.1186/1758-5996-6-100>. Go to original source... Go to PubMed...
  34. Aypak C, Turedi O, Yuce A et al. Thyroid-stimulating hormone (TSH) level in nutritionally obese children and metabolic co-morbidity. J Pediatr Endocrinol Metab 2013; 26(7-8): 703-708. Dostupné z DOI: <http://dx.doi.org/10.1515/jpem-2012-0384>. Go to original source... Go to PubMed...
  35. Karavani G, Strich D, Edri S et al. Increases in thyrotropin within the near-normal range are associated with increased triiodothyronine but not increased thyroxine in the pediatric age group. J Clin Endocrinol Metab 2014; 99(8): E1471-E1475. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014-1441>. Go to original source... Go to PubMed...
  36. Kobzova J, Vignerova J, Blaha P et al. The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Cent Eur J Public Health 2004; 12(3): 126-130.
  37. Hainer V, Zamrazilová H, Aldhoon-Hainerová I. Existuje metabolicky zdravá obezita? DMEV 2015; 18(3): 112-120.
  38. Hainer V, Aldhoon-Hainerová I, Zamrazilová H. Je metabolicky zdravá obezita přechodným stavem? Forum Diab 2016; 5(1): 6-11.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.